Anonymous
Guest
Anonymous
Guest
The contract with Depomed was announced today
The contract with Depomed was announced today
The contract with Depomed was announced today
Link?
Ugh. A re-launch of glumetza
Are these the ones that are looking for pain or CNS experience and successful launch experience?
Not to be a downer, but Gralise is just Neurontin repackaged. It's Amrix all over again. Gabapentin has been around for decades and is used off label for everything from restless legs to neuropathy. It's 10 bucks for generic. Huge territories. Oh yeah the bonus is 25% uncapped, but it will not be on any formulary so good luck with that. Here we go again. I'm out this time. Going for interview because I was called, but I will not take this or any pharma job again.
Depomed has another one ready to launch this year for hot flashes that may be added to the mix. Guess what it is?? GABAPENTIN-GR! Same drug with a new name and a new indication. This is what pharmaceuticals has been reduced to these days---just the same old stuff in a once or twice daily dose. I heard this forecasted 15 years ago at Eli Lilly and it has come to pass. The Wall Street Journal had an interesting article last week on this topic. There doesn't seem to be anything truly new on the horizon.
So, based on your comment, it is stupid to utilize cheaper, established drugs for new conditions, based on studies that show a positive effect. Lower cost to manufacture, lower cost to market, lower cost for Managed Care than completely new, novel meds where pharma companies need to recoup hundreds of millions in discovery/development expenses.
This is not the entire future of medicine, but it is a key part of controlling costs, for everyone in the chain. Get used to it.
Just tired of selling a $350 3rd tier drug against multiple $10 generics. Yes there are some tolerability and compliance benefits, but is it worth it really? On top of that, most of the products I have sold in the last 10 years have been quality-of-life drugs (Nuvigil, Ambien, Flomax, Amrix, Nexium) that go by the wayside when money gets tight. Also, to the above poster---I don't think we will ever see pharma researching cancer CURE. They are only interested in lifetime TREATMENT. If you want a really eye-opening experience, go to http://www.lef.org and read the articles and clinical trials on supplements and herbs and hormones that are not paid for by pharmaceutical companies. Life Extension is a 35 year old
non-profit foundation. Amazing.
No, it's not stupid but it's a dead end. Think for a second, the reason many older molecules have not been used for more indications is because any potential benefit is outweighed by the significant adverse effect and compliance issues associated with short-acting multiple dose meds, delivery system can have a significant positive impact on both those issues. And, when was the last time a generic company developed anything new? Whether you like it or not it's the profits from the US sales of brand name drugs that pays for R&D any new, novel, breakthrough therapies. You want to control costs by using all generics? Fine, then research will be frozen in time at today's date without any hope of finding a cure for the common cold, or cancer maybe. Good luck with that.